MNX1-AS1 and fatty liver disease: Further assays showed that MAYA silencing reversed HFD‐induced suppression of YAP in mice (Figure 7B), accompanied by a significant amelioration of iron overload, hepatic steatosis, lipid accumulation and hepatocyte senescence via iron content assay, H&E, Oil Red O staining and SA‐β‐gal staining (Figure 7C,7D).